Since PD-L1 blockade induced prolonged impairment of motor functon, we further performed EPM tests to assess the effects of PD-L1 blockade on anxiety-related behavior, one of hippocamus-related emotional deficit, on day 29 post-TBI (28 days after PD-L1 Ab treatment). The gene discussed is CD274; the disease is Anxiety.